Judson, I <br/><br/>
Phase I trial and pharmacokinetics of the tubulin inhibitor 1069C85--a synthetic agent binding at the colchicine site designed to overcome multidrug resistance.  [electronic resource] 

 -  British journal of cancer  1997 
 - 608-13 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/bjc.1997.107  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Antineoplastic Agents--pharmacokinetics<br/>Carbamates--pharmacokinetics<br/>Drug Administration Schedule<br/>Drug Resistance, Multiple<br/>Drug Resistance, Neoplasm<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Pyridazines--pharmacokinetics